scholarly journals Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial

2010 ◽  
Vol 3 (1) ◽  
pp. 9-18 ◽  
Author(s):  
Torello Lotti ◽  
Sergio Chimenti ◽  
Andreas Katsambas ◽  
Jean-Paul Ortonne ◽  
Louis Dubertret ◽  
...  
Keyword(s):  
Plaque Psoriasis ◽  
Efficacy And Safety ◽  
Treatment Results ◽  
Open Label ◽  
Severe Plaque Psoriasis ◽  
Phase Iiib ◽  
Open Label Phase

scholarly journals Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results

2009 ◽  
Vol 2 (4) ◽  
pp. 71-78 ◽  
Author(s):  
Fernando M. Stengel ◽  
Valeria Petri ◽  
Gladys A.M. Campbell ◽  
Gladys Leon Dorantes ◽  
Magdalina López ◽  
...  
Keyword(s):  
Latin American ◽  
Plaque Psoriasis ◽  
American Study ◽  
Latin American Study ◽  
Open Label ◽  
Severe Plaque Psoriasis ◽  
Study Results ◽  
Phase Iiib ◽  
Open Label Phase

scholarly journals Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

2016 ◽  
Vol 38 (9) ◽  
pp. 2058-2070.e1 ◽  
Author(s):  
Njira Lugogo ◽  
Christian Domingo ◽  
Pascal Chanez ◽  
Richard Leigh ◽  
Martyn J. Gilson ◽  
...  
Keyword(s):  
Efficacy And Safety ◽  
Open Label ◽  
Eosinophilic Asthma ◽  
Severe Eosinophilic Asthma ◽  
Term Efficacy ◽  
Phase Iiib ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document